Aemetis (AMTX) Upgraded to “Hold” at Zacks Investment Research

Aemetis (NASDAQ:AMTX) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued to investors on Thursday.

According to Zacks, “Aemetis, Inc. is an advanced fuels and renewable chemicals company. It produces renewable chemicals and fuels using patented microbes and processes. Aemetis owns and operates an ethanol animal feed plant in California to produce D5 Advanced Biofuels using the sorghum/biogas/CHP pathway. The Company also built, owns, and operates a renewable chemicals and advanced fuels production facility on the East Coast of India producing high quality, distilled biodiesel and refined glycerin for customers in Europe and Asia. Aemetis, Inc. is headquartered in Cupertino, California. “

Several other analysts also recently weighed in on the stock. B. Riley set a $2.00 target price on shares of Aemetis and gave the company a “hold” rating in a report on Monday, May 14th. Ascendiant Capital Markets assumed coverage on shares of Aemetis in a report on Tuesday, March 6th. They issued a “buy” rating and a $2.00 target price for the company.

Aemetis traded up $0.03, hitting $1.51, during trading on Thursday, Marketbeat Ratings reports. The company had a trading volume of 378 shares, compared to its average volume of 709,151. Aemetis has a 1-year low of $0.45 and a 1-year high of $3.12. The company has a current ratio of 0.20, a quick ratio of 0.09 and a debt-to-equity ratio of -1.40.

About Aemetis

Aemetis, Inc operates as a renewable fuels and bio-chemicals company in North America and India. The company focuses on the acquisition, development, and commercialization of various technologies that replace traditional petroleum-based products by the conversion of ethanol and biodiesel plants into advanced bio refineries.

Get a free copy of the Zacks research report on Aemetis (AMTX)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with's FREE daily email newsletter.

Leave a Reply